vs
丹麦皇冠（CCK）与奎斯特诊断（DGX）财务数据对比。点击上方公司名可切换其他公司
丹麦皇冠的季度营收约是奎斯特诊断的1.1倍（$3.3B vs $2.9B），奎斯特诊断净利率更高（9.7% vs 6.3%，领先3.4%），丹麦皇冠同比增速更快（12.9% vs 9.2%），过去两年奎斯特诊断的营收复合增速更高（9.9% vs 3.5%）
丹麦皇冠是来自丹麦的国际化食品企业，核心业务涵盖生猪、肉牛的屠宰加工及销售，旗下拥有多家子公司，业务覆盖食品行业多品类产品领域，首席执行官为尼尔斯·迪达尔，总部位于兰讷斯。
奎斯特诊断是美国头部临床检验服务商，位列《财富》500强，业务覆盖美国、波多黎各、墨西哥及巴西，同时与全球范围内多家医院、诊所保持长期协作关系，为不同地区的客户提供专业临床检验相关服务。
CCK vs DGX — 直观对比
营收规模更大
CCK
是对方的1.1倍
$2.9B
营收增速更快
CCK
高出3.7%
9.2%
净利率更高
DGX
高出3.4%
6.3%
两年增速更快
DGX
近两年复合增速
3.5%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $3.3B | $2.9B |
| 净利润 | $206.0M | $281.0M |
| 毛利率 | — | — |
| 营业利润率 | 11.2% | 15.4% |
| 净利率 | 6.3% | 9.7% |
| 营收同比 | 12.9% | 9.2% |
| 净利润同比 | -9.3% | 12.0% |
| 每股收益（稀释后） | $175.00 | $2.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCKDGX
| Q1 26 | $3.3B | $2.9B | ||
| Q4 25 | $3.1B | $2.8B | ||
| Q3 25 | $3.2B | $2.8B | ||
| Q2 25 | $3.1B | $2.8B | ||
| Q1 25 | $2.9B | $2.7B | ||
| Q4 24 | $2.9B | $2.6B | ||
| Q3 24 | $3.1B | $2.5B | ||
| Q2 24 | $3.0B | $2.4B |
净利润CCKDGX
| Q1 26 | $206.0M | $281.0M | ||
| Q4 25 | $150.0M | $245.0M | ||
| Q3 25 | $214.0M | $245.0M | ||
| Q2 25 | $181.0M | $282.0M | ||
| Q1 25 | $193.0M | $220.0M | ||
| Q4 24 | $358.0M | $222.0M | ||
| Q3 24 | $-175.0M | $226.0M | ||
| Q2 24 | $174.0M | $229.0M |
毛利率CCKDGX
| Q1 26 | — | — | ||
| Q4 25 | — | 32.4% | ||
| Q3 25 | — | 33.7% | ||
| Q2 25 | — | 34.2% | ||
| Q1 25 | — | 32.5% | ||
| Q4 24 | — | 32.7% | ||
| Q3 24 | — | 32.6% | ||
| Q2 24 | — | 33.5% |
营业利润率CCKDGX
| Q1 26 | 11.2% | 15.4% | ||
| Q4 25 | 12.0% | 13.8% | ||
| Q3 25 | 13.2% | 13.7% | ||
| Q2 25 | 12.4% | 15.9% | ||
| Q1 25 | 12.6% | 13.0% | ||
| Q4 24 | 12.1% | 13.8% | ||
| Q3 24 | 14.4% | 13.3% | ||
| Q2 24 | 12.5% | 14.8% |
净利率CCKDGX
| Q1 26 | 6.3% | 9.7% | ||
| Q4 25 | 4.8% | 8.7% | ||
| Q3 25 | 6.7% | 8.7% | ||
| Q2 25 | 5.7% | 10.2% | ||
| Q1 25 | 6.7% | 8.3% | ||
| Q4 24 | 12.3% | 8.5% | ||
| Q3 24 | -5.7% | 9.1% | ||
| Q2 24 | 5.7% | 9.6% |
每股收益（稀释后）CCKDGX
| Q1 26 | $175.00 | $2.24 | ||
| Q4 25 | $1.32 | $2.18 | ||
| Q3 25 | $1.85 | $2.16 | ||
| Q2 25 | $1.56 | $2.47 | ||
| Q1 25 | $1.65 | $1.94 | ||
| Q4 24 | $3.01 | $1.95 | ||
| Q3 24 | $-1.47 | $1.99 | ||
| Q2 24 | $1.45 | $2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $584.0M | $393.0M |
| 总债务越低越好 | $53.0M | $5.7B |
| 股东权益账面价值 | $3.4B | $7.7B |
| 总资产 | $14.3B | $16.7B |
| 负债/权益比越低杠杆越低 | 0.02× | 0.74× |
8季度趋势，按日历期对齐
现金及短期投资CCKDGX
| Q1 26 | $584.0M | $393.0M | ||
| Q4 25 | $764.0M | $420.0M | ||
| Q3 25 | $1.2B | $432.0M | ||
| Q2 25 | $936.0M | $319.0M | ||
| Q1 25 | $779.0M | $188.0M | ||
| Q4 24 | $918.0M | $549.0M | ||
| Q3 24 | $1.7B | $764.0M | ||
| Q2 24 | $1.4B | $271.0M |
总债务CCKDGX
| Q1 26 | $53.0M | $5.7B | ||
| Q4 25 | $5.9B | $5.2B | ||
| Q3 25 | $6.2B | $5.2B | ||
| Q2 25 | $6.3B | $5.2B | ||
| Q1 25 | $6.2B | $5.9B | ||
| Q4 24 | $6.1B | $5.6B | ||
| Q3 24 | $7.4B | $5.6B | ||
| Q2 24 | $7.3B | $3.8B |
股东权益CCKDGX
| Q1 26 | $3.4B | $7.7B | ||
| Q4 25 | $3.0B | $7.2B | ||
| Q3 25 | $3.0B | $7.3B | ||
| Q2 25 | $2.9B | $7.2B | ||
| Q1 25 | $2.7B | $6.9B | ||
| Q4 24 | $2.8B | $6.8B | ||
| Q3 24 | $2.5B | $6.8B | ||
| Q2 24 | $2.5B | $6.6B |
总资产CCKDGX
| Q1 26 | $14.3B | $16.7B | ||
| Q4 25 | $14.3B | $16.2B | ||
| Q3 25 | $14.6B | $16.2B | ||
| Q2 25 | $14.5B | $16.0B | ||
| Q1 25 | $13.8B | $15.8B | ||
| Q4 24 | $13.8B | $16.2B | ||
| Q3 24 | $15.1B | $16.1B | ||
| Q2 24 | $14.9B | $13.9B |
负债/权益比CCKDGX
| Q1 26 | 0.02× | 0.74× | ||
| Q4 25 | 1.96× | 0.72× | ||
| Q3 25 | 2.07× | 0.71× | ||
| Q2 25 | 2.18× | 0.72× | ||
| Q1 25 | 2.31× | 0.85× | ||
| Q4 24 | 2.23× | 0.83× | ||
| Q3 24 | 2.93× | 0.83× | ||
| Q2 24 | 2.92× | 0.58× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $278.0M |
| 自由现金流经营现金流 - 资本支出 | $-129.0M | — |
| 自由现金流率自由现金流/营收 | -4.0% | — |
| 资本支出强度资本支出/营收 | 2.7% | 3.9% |
| 现金转化率经营现金流/净利润 | — | 0.99× |
| 过去12个月自由现金流最近4个季度 | $1.0B | — |
8季度趋势，按日历期对齐
经营现金流CCKDGX
| Q1 26 | — | $278.0M | ||
| Q4 25 | $487.0M | $465.0M | ||
| Q3 25 | $580.0M | $563.0M | ||
| Q2 25 | $449.0M | $544.0M | ||
| Q1 25 | $14.0M | $314.0M | ||
| Q4 24 | $295.0M | $464.0M | ||
| Q3 24 | $554.0M | $356.0M | ||
| Q2 24 | $445.0M | $360.0M |
自由现金流CCKDGX
| Q1 26 | $-129.0M | — | ||
| Q4 25 | $255.0M | $307.0M | ||
| Q3 25 | $488.0M | $419.0M | ||
| Q2 25 | $393.0M | $436.0M | ||
| Q1 25 | $-19.0M | $197.0M | ||
| Q4 24 | $146.0M | $341.0M | ||
| Q3 24 | $478.0M | $250.0M | ||
| Q2 24 | $361.0M | $268.0M |
自由现金流率CCKDGX
| Q1 26 | -4.0% | — | ||
| Q4 25 | 8.2% | 10.9% | ||
| Q3 25 | 15.2% | 14.9% | ||
| Q2 25 | 12.5% | 15.8% | ||
| Q1 25 | -0.7% | 7.4% | ||
| Q4 24 | 5.0% | 13.0% | ||
| Q3 24 | 15.5% | 10.0% | ||
| Q2 24 | 11.9% | 11.2% |
资本支出强度CCKDGX
| Q1 26 | 2.7% | 3.9% | ||
| Q4 25 | 7.4% | 5.6% | ||
| Q3 25 | 2.9% | 5.1% | ||
| Q2 25 | 1.8% | 3.9% | ||
| Q1 25 | 1.1% | 4.4% | ||
| Q4 24 | 5.1% | 4.7% | ||
| Q3 24 | 2.5% | 4.3% | ||
| Q2 24 | 2.8% | 3.8% |
现金转化率CCKDGX
| Q1 26 | — | 0.99× | ||
| Q4 25 | 3.25× | 1.90× | ||
| Q3 25 | 2.71× | 2.30× | ||
| Q2 25 | 2.48× | 1.93× | ||
| Q1 25 | 0.07× | 1.43× | ||
| Q4 24 | 0.82× | 2.09× | ||
| Q3 24 | — | 1.58× | ||
| Q2 24 | 2.56× | 1.57× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CCK
| Americas Beverage | $1.5B | 47% |
| European Beverage | $588.0M | 18% |
| Transit Packaging | $496.0M | 15% |
| Other | $342.0M | 10% |
| Asia Pacific | $303.0M | 9% |
DGX
暂无分部数据
